Of mice and men: Hybridoma and recombinant antibodies

Immunology Today

Volumn 21, Issue 8, 2000, Pages 364-370

  Little, M ^a   Kipriyanov, S M ^a   Le Gall, F ^b   Moldenhauer, G ^b  

^a Dr Albert Reimann Straße 2   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CD4 ANTIGEN; DNA; DNA FRAGMENT; EPIDERMAL GROWTH FACTOR RECEPTOR; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOTOXIN; RECOMBINANT ANTIBODY;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN BINDING; BACTERIAL GROWTH; BIOENGINEERING; CELL FUSION; CLONING VECTOR; CONTROLLED STUDY; ESCHERICHIA COLI; GENE AMPLIFICATION; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HYBRIDOMA; IMMUNOGLOBULIN VARIABLE REGION; MAMMAL CELL; MILK; MOLECULAR CLONING; MOUSE; MOUSE STRAIN; MYELOMA CELL; NONHUMAN; OVARY CELL; PHAGE DISPLAY; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE; YEAST ARTIFICIAL CHROMOSOME;

ANIMALS; ANTIBODIES, MONOCLONAL; BACTERIA; BIOTECHNOLOGY; CELL LINE; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOGLOBULINS; MICE; MICE, TRANSGENIC; MILK; PLANTS, GENETICALLY MODIFIED; RECOMBINANT PROTEINS; TRANSFORMATION, GENETIC;

EID: 0033867593     PISSN: 01675699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5699(00)01668-6     Document Type: Review

References (44)

1. On immunity with special reference to cell life
2. Continuous cultures of fused cells secreting antibody of predefined specificity
3. Monoclonal antibodies: Principle and practice
4. Human monoclonal antibody production. Current status and future prospects
5. Creation of human tumor cells with defined genetic elements
6. Generation of recombinant antibodies
7. High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice
8. Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice
9. Antibody engineering via genetic engineering of the mouse: Xenomouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies
10. Double trans-chromosomic mice: Maintenance of two individual human chromosome fragments containing Ig heavy and kappa loci and expression of fully human antibodies
11. Human antibodies from transgenic mice
12. Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy
13. Human monoclonal antibodies: The emperor's new clothes
14. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli
15. A comparison of strategies to stabilize immunoglobulin Fv-fragments
16. Remodeling domain interfaces to enhance heterodimer formation
17. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli
18. Naturally occuring antibodies devoid of light chains
19. Improving the tumor specificity and retention of antibody-based molecules
20. 'Diabodies': Small bivalent and bispecific antibody fragments
21. Single-chain Fv fragments of antineuraminidase antibody NC10 containing five-and ten-residue linkers form dimers and with zero-residue linker a trimer
22. Di-, tri- and tetrameric single chain Fv antibody fragments against human CD19: Effect of valency on cell binding
23. Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics
24. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erb B-2 single-chain Fv
25. Efficient tumor cell lysis mediated by a bispecific single chain antibody expressed in Escherichia coli
26. Miniantibodies: Use of amphipathic helices to produce functional, flexibly linked dimeric Fv fragments with high avidity in Escherichia coli
27. Minibody: A novel engineered anticarcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts
28. Multivalent antibody fragments with high functional affinity for a tumor-associated carbohydrate antigen
29. Affinity enhancement of a recombinant antibody: Formation of complexes with multiple valency by a single-chain Fv fragment-core streptavidin fusion
30. In vitro production of monoclonal antibodies in high concentration in a new and easy to handle modular minifermenter
31. A comparison of monoclonal antibody productivity in different hollow fiber bioreactors
32. Protein expression in mammalian and insect cell systems
33. High-level expression of a recombinant antibody from myeloma cells using a gllutamine synthetase gene as an amplifiable selectable marker
34. Transgenic milk as a method for the production of recombinant antibodies
35. Production of goats by somatic cell nuclear transfer
36. Production of antibodies in transgenic plants
37. Generation and assembly of secretory antibodies in plants
38. Compartment-specific accumulation of recombinant immunoglobulins in plant cells: An essential tool for antibody production and immunomodulation of physiological functions and pathogen activity
39. Towards molecular farming in the future: Transient protein expression in plants
40. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli
41. The effect of folding catalyst on the in vivo folding process of different antibody fragments expressed in Escherichia coli
42. Selection for a periplasmic factor improving phage display and functional periplasmic expression
43. High level production of soluble single chain antibodies in small-scale Escherichia coli cultures
44. High volumetric yields of functional dimeric miniantibodies in Escherichia coli, using an optimized expression vector and high-cell-density fermentation under non-limited growth conditions